Sequenom Center for Molecular Medicine Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Sequenom Center for Molecular Medicine General Information

Description

Operator of a diagnostics laboratory. The company offers a range of molecular genetic laboratory tests and test for age related macular degeneration.

Contact Information

Website
www.cmmdx.org
Formerly Known As
Center for Molecular Medicine
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Acquirer
Primary Office
  • 301 Michigan Street North East
  • Suite 580
  • Grand Rapids, MI 49503
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sequenom Center for Molecular Medicine Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sequenom Center for Molecular Medicine‘s full profile, request access.

Request a free trial

Sequenom Center for Molecular Medicine Patents

Sequenom Center for Molecular Medicine Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2015252141-A1 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses Inactive 16-Sep-2009
AU-2017251674-A1 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses Active 16-Sep-2009
AU-2017251674-B2 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses Active 16-Sep-2009
AU-2019257485-A1 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses Active 16-Sep-2009
AU-2019257485-B2 Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses Active 16-Sep-2009 0
To view Sequenom Center for Molecular Medicine’s complete patent history, request access »

Sequenom Center for Molecular Medicine Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sequenom Center for Molecular Medicine‘s full profile, request access.

Request a free trial